XOMA Presents Results Demonstrating Novel Mechanism of Action for XOMA 052 in Regulating IL-1 Beta Levels Sep 30, 2009 7:00am EDT
XOMA to Develop Therapeutic Antibody for H1N1 and H5N1 Influenza Viruses Under $2.2 Million U.S. Government Program Managed by SRI International Sep 23, 2009 3:00pm EDT
XOMA Announces $6 Million Antibody Discovery Collaboration With Arana Therapeutics Sep 09, 2009 7:00am EDT
XOMA to Present At Canaccord Adams Global Growth Conference On August 12, 2009 Aug 10, 2009 4:26pm EDT
XOMA to Announce Second Quarter 2009 Financial Results and Host Conference Call on August 6 Aug 03, 2009 4:02pm EDT